Search
for

    Sort by

    Research 211–240 of 1000+

    1. 10 Complications Associated with PRP and Microneedling in Aesthetic Medicine 2019
    2. 022 Randomized, double-blind, placebo-controlled, single-centre, phase I safety study of intradermal injections of autologous fibroblasts isolated from the non-bulbar dermal sheath of the hair follicle to treat skin aging Journal of Investigative Dermatology · 2017
    3. Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors JAAD reviews. · 2025 · 1 citations
    4. Three Cases of Hemodialysis Patients with Advanced Gastric Cancer Treated with Paclitaxel and Nab Paclitaxel Annals of oncology · 2014 · 1 citations
    5. Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata JCI insight · 2016 · 222 citations
    6. Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis CNS drugs · 2016 · 29 citations
    7. Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata British Journal of Dermatology · 2024 · 23 citations
    8. Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata Journal of The American Academy of Dermatology · 2017 · 21 citations
    9. Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series Rheumatology and Therapy · 2017 · 16 citations
    10. Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis The Journal of Dermatology · 2024 · 7 citations
    11. [JAK INHIBITORS FOR THE TREATMENT OF ALOPECIA AREATA]. PubMed · 2020 · 4 citations
    12. Topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Efficacy findings from a phase I safety study. Journal of Clinical Oncology · 2016 · 2 citations
    13. LB1056 Phase 1b: Translational evaluation of VYN201, a pan-BD BET inhibitor, for the treatment of non-segmental vitiligo Journal of Investigative Dermatology · 2024 · 1 citations
    14. Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer Oncology Reviews · 2026
    15. Enhancing Mid‐Upper Facial Contours: Hairline Transplant Solutions for East Asian Women With High and Wide Foreheads Journal of Cosmetic Dermatology · 2025
    16. From the Cochrane Library: Interventions for Nail Psoriasis Dermatology · 2025
    17. Alopecia areata: Ritlecitinib generates substantial re-growth of scalp hair 2023
    18. Efficacy and safety of α-blockers plus 5α-reductase inhibitors for benign prostatic hyperplasia: a systematic review and meta-analysis European journal of medical research · 2026
    19. Real-World Effectiveness of JAK Inhibitors for Alopecia Totalis and Alopecia Universalis: A Single-Center Experience Journal of Cutaneous Medicine and Surgery · 2025
    20. Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2024
    21. JAK inhibitor deuruxolitinib shows encouraging hair re-growth in alopecia areata 2023
    22. Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape Wound practice & research · 2022
    23. Safety and efficacy of low-dose metronomic cyclophosphamide plus vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes. Journal of Clinical Oncology · 2018
    24. Cells to Surgery Quiz: April 2020 2020
    25. Efficacy and safety of JAK inhibitors in treating lichen planopilaris or frontal fibrosing alopecia Journal of the European Academy of Dermatology and Venereology · 2025 · 2 citations
    26. Treatment of Generalized Lichen Planus With Alefacept Archives of Dermatology · 2006 · 52 citations
    27. Dermatologic Side Effects of Systemic Targeted Anticancer Therapy Springer eBooks · 2018
    28. Drugs affecting blood coagulation, fibrinolysis, and hemostasis Side effects of drugs annual · 2009
    29. Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects Anais Brasileiros de Dermatologia · 2014 · 15 citations
    30. Dermatological drugs and topical agents Side effects of drugs annual · 2004